bannerbanner-m

Business Development & Partnership

Advancing critical care worldwide through partnership, innovation, and purpose.

Partnering to Advance Critical Care Worldwide

At Piramal Critical Care, saving and improving patients’ lives is more than a mission it is the foundation of everything we do. We collaborate with pharmaceutical and biotech partners to expand global access to differentiated critical care therapies.

Over the years, we have built a strong platform through strategic partnerships, acquisitions, and licensing initiatives that complement our capabilities in complex hospital generics and critical care. Our Business Development team actively engages with partners who share our commitment to quality, reliability, and meaningful patient impact.

who-we-wre

Who We Are

Piramal Critical Care is a global leader in inhaled anesthetics and a key player in hospital based critical care therapies, with a presence across the United States, Europe, and key emerging markets. Our portfolio spans anesthesia, pain management, intrathecal therapies, anti-infectives, neuromuscular blockers, and supportive care products.

We combine deep therapeutic expertise with a robust commercial infrastructure, regulatory excellence, and vertically integrated manufacturing to reliably bring complex products to market worldwide.

Our-Strategic-Focus

Our Strategic Focus

Our objective is to build sustainable, value creating partnerships that address unmet needs in acute and critical care settings. We actively evaluate opportunities aligned with our focus on critical care and hospital-based therapies, including

  • Inhaled Anesthesia

    Inhalation anesthesia

  • Generic Injectables

    Injectable pain and anesthesia products

  • osf-icon3

    Intrathecal and CNS therapies

  • osf-icon4

    Hospital anti-infectives

  • osf-icon5

    Niche, differentiated, and shortage driven products

Partnership-Models

Partnership Models

Each opportunity is assessed based on strategic alignment, long-term value creation, and global scalability. We remain open to a range of flexible collaboration models, including

  • pm-icon1

    In licensing and out licensing arrangements

  • pm-icon2

    Co-development partnerships

  • pm-icon3

    Product or portfolio acquisitions

  • pm-icon4

    ANDA and NDA purchases

  • pm-icon5

    Co-marketing and promotional alliances

Why Partner with Piramal Critical Care

Partners choose Piramal Critical Care for our ability to execute:

  • Established global commercial and marketing infrastructure
  • Strong regulatory and quality track record
  • Proven experience in complex hospital products
  • Reliable global supply chain and manufacturing capabilities
  • A collaborative, long term partnership mindset
why-partner

We bring more than capital we bring operational depth, market access, and a commitment to shared success.

Our Approach

Our Business Development team works closely with internal technical, regulatory, commercial, and legal teams to evaluate opportunities efficiently and transparently. We focus on building partnerships that are scientifically sound, commercially viable, and aligned with our mission to improve patient outcomes.

contact-uscontact-us-m

Contact Us

We welcome collaboration opportunities in critical care.

PCC.BD@piramal.com